Manufacturer:

          Sanofi-Aventis

Contents:

          Glimepiride

Indications:

          Alone or in combination w/ insulin or metformin in the treatment of NIDDM.

Contraindications:

          Insulin-dependent (type 1) DM; diabetic ketoacidosis; diabetic precoma or coma; hypersensitivity to glimepiride or any of its excipients, other sulfonylureas or sulfonamides; serious renal or hepatic dysfunction; dialysis patients. Pregnancy & lactation.

Special Precautions:

          Regular monitoring of glucose levels in blood & urine. Milder or absent symptoms of hypoglycaemia eg in patients w/ autonomic neuropathy or taking β-blockers, clonidine, reserpine, guanethidine or other sympatholytic drugs. Temporary changeover to insulin in exceptional stress situations (eg trauma, surgery, infections w/ fever).

Dosage:

          Initially 1 mg once daily. Usual maintenance dose: 1-4 mg once daily. Max daily dose: 6 mg (& in exceptional cases, 8 mg). Amaryl may also be used in combination w/ insulin or metformin.

Class:

          Antidiabetic Agents

Presentation/Packing:

          Amaryl tablet

Details:

          MyPhuocPharmacy – (08) 62581003